EVALUATION OF HEMATOLOGY CONSULTATIONS IN COVID-19 PANDEMIC

This study aims to evaluate the COVID-19 pandemic consultations requested from the division of hematology in the hospital. We recorded the following features of the patients: demographic information, the status of outpatient or inpatient, the clinic requested consultation, the result of the consultation, having a hematological disease, diagnosis and COVID-19 suspicion. In this study, 82 cases were evaluated. The median age of the patients was 49,5. Females were mild higher (56,1% vs. 43,9%). Eight of the patients was suspected with COVID-19. The frequency of suspicion in patients with the previously diagnosed hematological disorder was higher significantly than patients without previously diagnosed (42,9% vs. 6,7% p=0,018). The frequency of suspicion was higher significantly inpatients than outpatients (19,4% vs. 2,2%, p=0,019). Only two of the patients who was suspected with COVID-19 were PCR-positive and these patients were diagnosed with concomitant hematologic malignancy; CLL and MCL. The most common clinic and cause of this consultation of this clinic were gynecology and thrombocytopenia, respectively, and most of the patients were diagnosed with pseudothrombocytopenia. After the consultation for all patients, the diagnosis was drug-related cytopenia; however, detailed evaluation for cytopenia was delayed to period which after the pandemic because any patients had no deep levels of cytopenia. Although our study has some limitations, this study is remarkable because this is the first study that has investigated hematology consultation during the pandemic. We think that more significant results will be achieved as new data become available, as long as the pandemic continues.